Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial

Background and Purpose: Edaravone dexborneol, comprised of 2 active ingredients, edaravone and (+)-borneol, has been developed as a novel neuroprotective agent with synergistic effects of antioxidant and anti-inflammatory in animal models. The present clinical trial aimed at testing the effects of e...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Stroke (1970) 2021-03, Vol.52 (3), p.772-780
Hauptverfasser:	Xu, Jie, Wang, Anxin, Meng, Xia, Yalkun, Gulbahram, Xu, Anding, Gao, Zhiqiang, Chen, Huisheng, Ji, Yong, Xu, Jun, Geng, Deqin, Zhu, Runxiu, Liu, Bo, Dong, Aiqin, Mu, Hua, Lu, Zhihong, Li, Shuya, Zheng, Huaguang, Chen, Xia, Wang, Yilong, Zhao, Xingquan, Wang, Yongjun
Format:	Artikel
Sprache:	eng
Schlagworte:	Cardiovascular System & Cardiology Clinical Neurology Life Sciences & Biomedicine Neurosciences & Neurology Peripheral Vascular Disease Science & Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!